Brighthouse Financial
BHF · Life & Health Insurance
$45.41
2.0%Globe Life
GL · Life & Health Insurance
$154.79
8.1%The short version
- Brighthouse Financial is the larger business, with $6.8B of revenue in fiscal 2025 against $6.0B for Globe Life.
- Brighthouse Financial grew revenue faster (43.2%, against 3.7%).
- Investors pay more for each dollar of Globe Life’s earnings: a P/E of 10.3x against 3.6x for Brighthouse Financial.
| Latest fiscal year | BHF · FY25 | GL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.6B | $12.2B |
| Revenue | $6.8B | $6.0B |
| Free cash flow | — | $1.3B |
| Net income | $433M | $1.2B |
| Growth | ||
| Revenue growth | 43.2% | 3.7% |
| 5-year growth | −4.5% | 4.8% |
| Share count change | −5.9% | −8.0% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | 6.4% | 19.4% |
| FCF margin | — | 20.9% |
| Return on capital | — | 16.0% |
| Return on equity | — | 20.6% |
| Balance sheet | ||
| Net debt | −$3.4B | $2.2B |
| Net debt / EBITDA | — | 1.4x |
| Dividends and buybacks | $102M | $967M |
| Valuation & quality | ||
| P/E | 3.6x | 10.3x |
| Piotroski F-score | — | — |
FY16
BHF $3.0B
GL $3.9B
FY17
BHF $6.8B
GL $4.2B
FY18
BHF $9.0B
GL $4.3B
FY19
BHF $6.6B
GL $4.5B
FY20
BHF $8.5B
GL $4.7B
FY21
BHF $5.0B
GL $5.1B
FY22
BHF $6.9B
GL $5.2B
FY23
BHF $4.1B
GL $5.4B
FY24
BHF $4.7B
GL $5.8B
FY25
BHF $6.8B
GL $6.0B
BHF
GL
FY16
BHF —
GL 20.0%
FY17
BHF —
GL 19.8%
FY18
BHF —
GL 20.2%
FY19
BHF —
GL 20.3%
FY20
BHF —
GL 19.1%
FY21
BHF —
GL 24.0%
FY22
BHF —
GL 22.7%
FY23
BHF —
GL 23.2%
FY24
BHF —
GL —
FY25
BHF —
GL —
BHF
GL
FY16
BHF —
GL $1.4B
FY17
BHF —
GL $1.4B
FY18
BHF —
GL $1.2B
FY19
BHF —
GL $1.3B
FY20
BHF —
GL $1.4B
FY21
BHF —
GL $1.4B
FY22
BHF —
GL $1.4B
FY23
BHF —
GL $1.4B
FY24
BHF —
GL $1.3B
FY25
BHF —
GL $1.3B
BHF
GL
FY16
BHF —
GL 10.0%
FY17
BHF —
GL 12.4%
FY18
BHF —
GL 9.9%
FY19
BHF —
GL 9.6%
FY20
BHF —
GL 7.7%
FY21
BHF —
GL 13.7%
FY22
BHF —
GL 19.3%
FY23
BHF —
GL 16.6%
FY24
BHF —
GL 16.5%
FY25
BHF —
GL 16.0%
BHF
GL
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.